224 related articles for article (PubMed ID: 32325781)
1. Flaxseed (
Kanikowska D; Korybalska K; Mickiewicz A; Rutkowski R; Kuchta A; Sato M; Kreft E; Fijałkowski M; Gruchała M; Jankowski M; Bręborowicz A; Witowski J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325781
[TBL] [Abstract][Full Text] [Related]
2. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia.
Wong H; Chahal N; Manlhiot C; Niedra E; McCrindle BW
JAMA Pediatr; 2013 Aug; 167(8):708-13. PubMed ID: 23733031
[TBL] [Abstract][Full Text] [Related]
3. Effect of Flaxseed (
Kanikowska D; Malińska A; Mickiewicz A; Zawada A; Rutkowski R; Pawlaczyk K; Sato M; Bręborowicz A; Witowski J; Korybalska K
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889835
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
Bambauer R; Schiel R; Latza R
Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
[TBL] [Abstract][Full Text] [Related]
5. Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis.
Weylandt KH; Schmöcker C; Ostermann AI; Kutzner L; Willenberg I; Kiesler S; Steinhagen-Thiessen E; Schebb NH; Kassner U
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30744123
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of flaxseed formulation as a potential therapeutic agent in mitigation of dyslipidemia.
Saxena S; Katare C
Biomed J; 2014; 37(6):386-90. PubMed ID: 25163498
[TBL] [Abstract][Full Text] [Related]
7. A new genotype of flax (Linum usitatissimum L.) with decreased susceptibility to fat oxidation: consequences to hematological and biochemical profiles of blood indices.
Króliczewska B; Miśta D; Króliczewski J; Zawadzki W; Kubaszewski R; Wincewicz E; Żuk M; Szopa J
J Sci Food Agric; 2017 Jan; 97(1):165-171. PubMed ID: 26956460
[TBL] [Abstract][Full Text] [Related]
8. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
[TBL] [Abstract][Full Text] [Related]
9. From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.
Zenti MG; Altomari A; Lupo MG; Botta M; Bonora E; Corsini A; Ruscica M; Ferri N
Eur J Prev Cardiol; 2018 Nov; 25(17):1843-1851. PubMed ID: 30058841
[TBL] [Abstract][Full Text] [Related]
10. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities.
Khalatbari Soltani S; Jamaluddin R; Tabibi H; Mohd Yusof BN; Atabak S; Loh SP; Rahmani L
Hemodial Int; 2013 Apr; 17(2):275-81. PubMed ID: 22998533
[TBL] [Abstract][Full Text] [Related]
11. The scientific basis and future of lipoprotein apheresis.
Thompson GR
Ther Apher Dial; 2022 Feb; 26(1):32-36. PubMed ID: 34331508
[TBL] [Abstract][Full Text] [Related]
12. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.
Hillebrant CG; Nyberg B; Einarsson K; Eriksson M
Gut; 1997 Nov; 41(5):700-4. PubMed ID: 9414982
[TBL] [Abstract][Full Text] [Related]
13. Flaxseed Supplementation Reduces Plasma Lipoprotein(a) Levels: A Meta-Analysis.
Sahebkar A; Katsiki N; Ward N; Reiner Ž
Altern Ther Health Med; 2021 May; 27(3):50-53. PubMed ID: 31634874
[TBL] [Abstract][Full Text] [Related]
14. NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study).
Schettler VJ; Muellendorff F; Schettler E; Platzer C; Norkauer S; Julius U; Neumann CL
Ther Apher Dial; 2019 Oct; 23(5):467-473. PubMed ID: 30663261
[TBL] [Abstract][Full Text] [Related]
15. Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report.
Zenti MG; Stefanutti C; Sanga V; Altomari A; Fabris A; Dauriz M; Bonora E
J Clin Apher; 2018 Aug; 33(4):546-550. PubMed ID: 29638018
[TBL] [Abstract][Full Text] [Related]
16. A lipidomic analysis approach in patients undergoing lipoprotein apheresis.
Schmöcker C; Kassner U; Kiesler S; Bismarck M; Rothe M; Steinhagen-Thiessen E; Weylandt KH
Atherosclerosis; 2016 Jun; 249():30-5. PubMed ID: 27062407
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience.
Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H
Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.
Chen TS; Liou SY; Wu HC; Tsai FJ; Tsai CH; Huang CY; Chang YL
Int Urol Nephrol; 2011 Jun; 43(2):471-4. PubMed ID: 20229247
[TBL] [Abstract][Full Text] [Related]
19. Effects of flaxseed supplementation on weight loss, lipid profiles, glucose, and high-sensitivity C-reactive protein in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Sabet HR; Ahmadi M; Akrami M; Motamed M; Keshavarzian O; Abdollahi M; Rezaei M; Akbari H
Clin Cardiol; 2024 Jan; 47(1):e24211. PubMed ID: 38269632
[TBL] [Abstract][Full Text] [Related]
20. Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents.
Machado AM; de Paula H; Cardoso LD; Costa NM
Nutrition; 2015 Jan; 31(1):90-6. PubMed ID: 25441591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
